Mono Pharmacare Limited (NSE: MONOPHARMA)
India
· Delayed Price · Currency is INR
33.00
+0.90 (2.80%)
At close: Dec 24, 2024
Mono Pharmacare Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
Cash & Equivalents | 1.31 | 3.63 | 4.18 | 2.45 | 1.73 | 3.55 |
Cash & Short-Term Investments | 1.31 | 3.63 | 4.18 | 2.45 | 1.73 | 3.55 |
Cash Growth | -95.16% | -13.17% | 70.70% | 41.28% | -51.25% | - |
Accounts Receivable | 458.42 | 315.9 | 218.71 | 55.21 | 53.47 | 33.22 |
Other Receivables | - | - | - | - | - | 0.22 |
Receivables | 458.42 | 315.9 | 218.71 | 55.21 | 53.47 | 33.44 |
Inventory | 477.43 | 422.93 | 326.86 | 47.14 | 41.41 | 29.54 |
Other Current Assets | 47.53 | 59.18 | 61.33 | 36.07 | 11.73 | 16.09 |
Total Current Assets | 984.69 | 801.64 | 611.07 | 140.86 | 108.34 | 82.62 |
Property, Plant & Equipment | 9.91 | 8.99 | 8.26 | 2.97 | 3.91 | 4.55 |
Long-Term Investments | - | - | 5.73 | - | - | - |
Other Intangible Assets | 0.12 | 0.13 | 0.01 | - | - | - |
Long-Term Deferred Tax Assets | 0.19 | 0.12 | 0.53 | - | - | - |
Other Long-Term Assets | 0 | - | 0.15 | - | - | - |
Total Assets | 995.16 | 811.13 | 625.74 | 143.83 | 112.25 | 87.17 |
Accounts Payable | 172.88 | 96.85 | 69.37 | 33.46 | 12.55 | 2.74 |
Accrued Expenses | 16.63 | 6.23 | 3.91 | 0.98 | 1.22 | 0.61 |
Short-Term Debt | 267.95 | 243.16 | 246.02 | 49.26 | 50.95 | 56.94 |
Current Income Taxes Payable | - | - | 8.87 | 1.96 | 0.72 | 0.28 |
Other Current Liabilities | 13.57 | 11.94 | 7.43 | 0.28 | 0 | - |
Total Current Liabilities | 471.03 | 358.17 | 335.61 | 85.94 | 65.43 | 60.57 |
Long-Term Debt | 219.16 | 171.25 | 153.25 | 15.14 | 9.86 | 6.41 |
Other Long-Term Liabilities | 0.68 | 0.43 | - | 0 | -0 | - |
Total Liabilities | 690.87 | 529.84 | 488.85 | 101.07 | 75.29 | 66.98 |
Common Stock | 176.96 | 176.88 | 123.69 | 42.76 | 36.96 | 20.19 |
Additional Paid-In Capital | - | - | 4.89 | - | - | - |
Retained Earnings | - | - | 8.28 | - | - | - |
Comprehensive Income & Other | 127.06 | 104.21 | - | - | - | - |
Total Common Equity | 304.02 | 281.09 | 136.86 | 42.76 | 36.96 | 20.19 |
Minority Interest | 0.27 | 0.19 | 0.03 | - | - | - |
Shareholders' Equity | 304.29 | 281.28 | 136.89 | 42.76 | 36.96 | 20.19 |
Total Liabilities & Equity | 995.16 | 811.13 | 625.74 | 143.83 | 112.25 | 87.17 |
Total Debt | 487.11 | 414.4 | 399.27 | 64.39 | 60.8 | 63.35 |
Net Cash (Debt) | -485.8 | -410.78 | -395.09 | -61.95 | -59.07 | -59.79 |
Net Cash Per Share | -27.36 | -26.57 | -69.75 | -12.60 | -12.01 | -12.16 |
Filing Date Shares Outstanding | 17.64 | 17.87 | 12.37 | 4.92 | 4.92 | 4.92 |
Total Common Shares Outstanding | 17.64 | 17.87 | 12.37 | 4.92 | 4.92 | 4.92 |
Working Capital | 513.66 | 443.47 | 275.46 | 54.93 | 42.9 | 22.05 |
Book Value Per Share | 17.24 | 15.73 | 11.06 | 8.69 | 7.52 | 4.11 |
Tangible Book Value | 303.9 | 280.96 | 136.85 | 42.76 | 36.96 | 20.19 |
Tangible Book Value Per Share | 17.23 | 15.72 | 11.06 | 8.69 | 7.52 | 4.11 |
Buildings | - | - | 4.7 | - | - | - |
Machinery | - | - | 5.19 | 6.43 | 6.29 | 5.65 |
Source: S&P Capital IQ. Standard template. Financial Sources.